Reproductive factors and clinical features of Parkinson's disease

Parkinsonism and Related Disorders

Volumn 19, Issue 12, 2013, Pages 1094-1099

  Cereda, Emanuele ^a   Barichella, Michela ^b   Cassani, Erica ^b   Caccialanza, Riccardo ^a   Pezzoli, Gianni ^b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b PARKINSON INSTITUTE   (Italy)

Author keywords

Clinical features; Estrogens; Parkinson's disease; Reproductive factors

Indexed keywords

ESTROGEN; LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTRACEPTIVE BEHAVIOR; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DRUG EXPOSURE; ESTROGEN THERAPY; FEMALE; FEMALE GENITAL SYSTEM FUNCTION; FERTILE PERIOD; HOEHN AND YAHR SCALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; MENSTRUATION; NIGRONEOSTRIATAL SYSTEM; ONSET AGE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; REPRODUCTIVE FACTOR; RISK FACTOR; SPONTANEOUS ABORTION; SYMPTOM ASSESSMENT; TREATMENT DURATION; TREMOR; UNIFIED PARKINSON DISEASE RATING SCALE;

CLINICAL FEATURES; ESTROGENS; PARKINSON'S DISEASE; REPRODUCTIVE FACTORS;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; PARKINSON DISEASE; REPRODUCTIVE HISTORY;

EID: 84889086827     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.07.020     Document Type: Article

References (33)

1. Lees A.J., Hardy J., Revesz T. Parkinson's disease. Lancet 2009, 373:2055-2066.
2. Zimprich A. Genetics of Parkinson's disease and essential tremor. Curr Opin Neurol 2011, 24:318-323.
3. Barichella M., Cereda E., Pezzoli G. Major nutritional issues in the management of Parkinson's disease. Mov Disord 2009, 24:1881-1892.
4. Cereda E., Barichella M., Pedrolli C., Pezzoli G. Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis. Diabetes Care 2011, 34:2614-2623.
5. Qiu C., Hu G., Kivipelto M., Laatikainen T., Antikainen R., Fratiglioni L., et al. Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study. Hypertension 2011, 57:1094-1100.
6. Ritz B., Ascherio A., Checkoway H., Marder K.S., Nelson L.M., Rocca W.A., et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 2007, 64:990-997.
7. Sofi F., Abbate R., Gensini G.F., Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 2010, 92:1189-1196.
8. Hernán M.A., Takkouche B., Caamaño-Isorna F., Gestal-Otero J.J. Ameta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 2002, 52:276-284.
9. Pezzoli G., Cereda E. Exposure to pesticides or solvents and risk of Parkinson's disease. Neurology 2013, 80:2035-2041.
10. Ragonese P., D'Amelio M., Salemi G., Aridon P., Gammino M., Epifanio A., et al. Risk of Parkinson disease in women: effect of reproductive characteristics. Neurology 2004, 62:2010-2014.
11. Currie L.J., Harrison M.B., Trugman J.M., Bennett J.P., Wooten G.F. Postmenopausal estrogen use affects risk for Parkinson disease. Arch Neurol 2004, 61:886-888.
12. Ragonese P., D'Amelio M., Callari G., Salemi G., Morgante L., Savettieri G. Age at menopause predicts age at onset of Parkinson's disease. Mov Disord 2006, 21:2211-2214.
13. Saunders-Pullman R., Derby C., Santoro N., Bressman S., Chiu B., Lipton R.B., et al. Role of endogenous and exogenous hormone exposure on the risk of Parkinson's disease: results from the Women's Health Initiative Observational Study. Abstracts of the 61st meeting of the American Academy of Neurology. Neurology 2009, 72:S23.
14. Simon K.C., Chen H., Gao X., Schwarzschild M.A., Ascherio A. Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease. Mov Disord 2009, 24:1359-1365.
15. Popat R.A., Van Den Eeden S.K., Tanner C.M., McGuire V., Bernstein A.L., Bloch D.A., et al. Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease. Neurology 2005, 65:383-390.
16. Nicoletti A., Nicoletti G., Arabia G., Annesi G., De Mari M., Lamberti P., et al. Reproductive factors and Parkinson's disease: a multicenter case-control study. Mov Disord 2011, 26:2563-2566.
17. Rugbjerg K., Christensen J., Tjønneland A., Olsen J.H. Exposure to estrogen and women's risk for Parkinson's disease: a prospective cohort study in Denmark. Parkinsonism Relat Disord 2013, 19:457-460.
18. Wooten G.F., Currie L.J., Bovbjerg V.E., Lee J.K., Patrie J. Are men at greater risk for Parkinson's disease than women?. JNeurol Neurosurg Psychiatry 2004, 75:637-639.
19. Twelves D., Perkins K.S., Counsell C. Systematic review of incidence studies of Parkinson's disease. Mov Disord 2003, 18:19-31.
20. Haaxma C.A., Bloem B.R., Borm G.F., Oyen W.J., Leenders K.L., Eshuis S., et al. Gender differences in Parkinson's disease. JNeurol Neurosurg Psychiatry 2007, 78:819-824.
21. Gillies G.E., McArthur S. Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: a contribution to sex-specific neuroprotection by estrogens. Horm Behav 2010, 57:23-34.
22. Liu B., Dluzen D.E. Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease. Clin Exp Pharmacol Physiol 2007, 34:555-565.
23. Saunders-Pullman R., Gordon-Elliott J., Parides M., Fahn S., Saunders H.R., Bressman S. The effect of estrogen replacement on early Parkinson's disease. Neurology 1999, 52:1417-1420.
24. Arandomized pilot trial of estrogen replacement therapy in post-menopausal women with Parkinson's disease. Parkinsonism Relat Disord 2011, 17:757-760. Parkinson Study Group POETRY Investigators.
25. Tsang K.L., Ho S.L., Lo S.K. Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations. Neurology 2000, 54:2292-2298.
26. Pezzoli G., Canesi M., Antonini A., Righini A., Perbellini L., Barichella M., et al. Hydrocarbon exposure and Parkinson's disease. Neurology 2000, 55:667-673.
27. Martignoni E., Nappi R.E., Citterio A., Calandrella D., Zangaglia R., Mancini F., et al. Parkinson's disease and reproductive life events. Neurol Sci 2002, 23:S85-S86.
28. Bourque M., Dluzen D.E., Di Paolo T. Neuroprotective actions of sex steroids in Parkinson's disease. Front Neuroendocrinol 2009, 30:142-157.
29. Benedetti M.D., Maraganore D.M., Bower J.H., McDonnell S.K., Peterson B.J., Ahlskog J.E., et al. Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study. Mov Disord 2001, 16:830-837.
30. Chen S., Nilsen J., Brinton R.D. Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications. Endocrinology 2006, 147:5303-5313.
31. Xia R., Mao Z.H. Progression of motor symptoms in Parkinson's disease. Neurosci Bull 2012, 28:39-48.
32. Veliskova J., Moshe S.L. Sexual dimorphism and developmental regulation of substantia nigra function. Ann Neurol 2001, 50:596-601.
33. Ascherio A., Chen H., Schwarzschild M.A., Zhang S.M., Colditz G.A., Speizer F.E., et al. Caffeine, postmenopausal estrogen, and risk of Parkinson's disease. Neurology 2003, 60:790-795.